Dtsch Med Wochenschr 2006; 131(46): 2605-2609
DOI: 10.1055/s-2006-956257
Übersicht | Review article
Hypertensiologie, Nephrologie
© Georg Thieme Verlag KG Stuttgart · New York

Dialyse und Hypertonie

Haemodialysis and hypertensionM. van der Giet1 , W. Zidek1
  • 1Medizinische Klinik IV - Nephrologie, Charite - Campus Benjamin Franklin, Berlin
Further Information

Publication History

eingereicht: 3.7.2006

akzeptiert: 14.9.2006

Publication Date:
09 November 2006 (online)

Literatur

  • 1 Consensus Development Conference Panel. Morbidity and mortality of renal dialysis: an NIH consensus conference statement . Ann Intern Med. 1994;  121 62-70
  • 2 Agarwal R. Exploring the paradoxical relationship of hypertension with mortality in chronic hemodialysis.  Hemodialysis Int. 2004;  8 208
  • 3 Agarwal R. Hypertension and survival in chronic hemodialysis patients - past lessons and future opportunities.  Kidney Int. 2005;  67 1-13
  • 4 Agarwal R. Hypertension in chronic kidney disease and dialysis: pathophysiology and management.  Cardiol Clin. 2005;  23 237-248
  • 5 Agarwal R. Hypertension diagnosis and prognosis in chronic kidney disease with out-of-office blood pressure monitoring.  Curr Opin Nephrol Hypertens. 2006;  15 309-313
  • 6 Agarwal R, Nissenson A R, Batlle D, Coyne D W, Trout J R, Warnock D G. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States.  Am J Med. 2003;  115 291-297
  • 7 Boutitie F, Gueyffier F, Pocock S, Fagard R, Boissel J P. J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data.  Ann Intern Med. 2002;  136 438-448
  • 8 Charra B, Calemard E, Ruffet M, Chazot C, Terrat J C, Vanel T. et al . Survival as an index of adequacy of dialysis.  Kidney Int. 1992;  41 1286-1291
  • 9 Chazot C, Charra B, Vo Van C, Jean G, Vanel T, Calemard E. et al . The Janus-faced aspect of ‘dry weight’.  Nephrol Dial Transplant. 1999;  14 121-124
  • 10 de Paula F M, Peixoto A J, Pinto L V, Dorigo D, Patricio P J, Santos S F. Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients.  Kidney Int. 2004;  66 1232-1238
  • 11 Duranti E, Imperiali P, Sasdelli M. Is hypertension a mortality risk factor in dialysis?.  Kidney Int Suppl. 1996;  55 S173-174
  • 12 Foley R N, Parfrey P S. Cardiovascular disease and mortality in ESRD.  J Nephrol. 1998;  11 239-245
  • 13 Himmelfarb J, Stenvinkel P, Ikizler T A, Hakim R M. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia.  Kidney Int. 2002;  62 1524-1538
  • 14 Jaeger J Q, Mehta R L. Assessment of dry weight in hemodialysis: an overview.  J Am Soc Nephrol. 1999;  10 392-403
  • 15 Kalantar-Zadeh K. Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: What is next?.  Semin Dial. 2005;  18 365-369
  • 16 Kalantar-Zadeh K, Block G, Humphreys M H, Kopple J D. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.  Kidney Int. 2003;  63 793-808
  • 17 Kalantar-Zadeh K, Kilpatrick R D, McAllister C J, Greenland S, Kopple J D. Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions.  Hypertension. 2005;  45 811-817
  • 18 Kestenbaum B, Gillen D L, Sherrard D J, Seliger S, Ball A, Stehman-Breen C. Calcium channel blocker use and mortality among patients with end-stage renal disease.  Kidney Int. 2002;  61 2157-2164
  • 19 Klassen P S, Lowrie E G, Reddan D N, DeLong E R, Coladonato J A, Szczech L A. et al . Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis.  Jama. 2002;  287 1548-1555
  • 20 Mazzuchi N, Carbonell E, Fernandez-Cean J. Importance of blood pressure control in hemodialysis patient survival.  Kidney Int. 2000;  58 2147-2154
  • 21 Salem M M. Hypertension in the haemodialysis population: any relationship to 2-years survival?.  Nephrol Dial Transplant. 1999;  14 125-128
  • 22 Takeda A, Toda T, Fujii T, Shinohara S, Sasaki S, Matsui N. Discordance of influence of hypertension on mortality and cardiovascular risk in hemodialysis patients.  Am J Kidney Dis. 2005;  45 112-118
  • 23 Tomita J, Kimura G, Inoue T, Inenaga T, Sanai T, Kawano Y. et al . Role of systolic blood pressure in determining prognosis of hemodialyzed patients.  Am J Kidney Dis. 1995;  25 405-412
  • 24 Tozawa M, Iseki K, Fukiyama K. Hypertension in dialysis patients: a cross-sectional analysis.  Nippon Jinzo Gakkai Shi. 1996;  38 129-135
  • 25 Zager P G, Nikolic J, Brown R H, Campbell M A, Hunt W C, Peterson D. et al . „U” curve association of blood pressure and mortality in hemodialysis patients.  Medical Directors of Dialysis Clinic, Inc Kidney Int. 1998;  54 561-569
  • 26 Zazgornik J, Biesenbach G, Janko O, Gross C, Mair R, Brucke P. et al . Bilateral nephrectomy: the best, but often overlooked, treatment for refractory hypertension in hemodialysis patients.  Am J Hypertens. 1998;  11 1364-1370

Prof. Dr. med. Markus van der Giet

Charite - Campus Benjamin Franklin, Med. Klinik IV - Nephrologie

Hindenburgdamm 30

12200 Berlin

Phone: +49/30/84453021

Fax: +49/30/84453338

Email: markus.vandergiet@charite.de

    >